The Clinical Study on Treating Acute Gouty Arthritis Using Both Internal and External Therapy of Tonifying Spleen and Descending Turbid

• ClinicalTrials.gov Identifier: NCT02545777
• Recruitment Status: Unknown
• First Posted: September 10, 2015
• Last Update Posted: September 11, 2015
• Sponsor: Beijing University of Chinese Medicine
• Information provided by (Responsible Party): Wang Shidong, Beijing University of Chinese Medicine

Study Description

Brief Summary:

This research is based on spleen trapped by dampness and turbid which is the pathogenesis of gouty arthritis.It uses effective prescription of Endocrinology of Dongzhimen Hospital.In this study, the investigators use multi-center randomized parallel controlled clinical trials.The treatment groups are afforded oral traditional Chinese medicine decoction-tonifying spleen and descending the turbid decoction as well as soaking and wet wrapping.The control groups are afforded diclofenac sodium enteric-coated tablets as a positive control drug.The outcome is evaluated by condition of symptoms remission,pain relief time, recurrence rate and laboratory index to determine the efficacy of internal and external treatment.And the research will provide optimized diagnosis and treatment program. The investigators hope this research will also get tonifying spleen and descending the turbid internal and external treatment for gouty arthritis effective clinical treatment.

Condition or disease	Intervention/treatment	Phase
Acute Gouty Arthritis	Drug: diclofenac sodium enteric-coated; Drug: Oral medicine of tonifying spleen and descending turbid; Drug: Steeping and washing medicine of descending turbid and clearing heat; Drug: Wet wrapping medicine of descending turbid and clearing heat	Phase 2

Study Design

• Study Type: Interventional (Clinical Trial)
• Estimated Enrollment: 120 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: Single (Outcomes Assessor)
• Primary Purpose: Treatment
• Study Start Date: May 2014
• Estimated Primary Completion Date: December 2015

Arms and Interventions

Arm	Intervention/treatment
Active Comparator: treatment group; Take oral medicine of tonifying spleen and descending turbid, one bag each time, two times a day, continuous treatment for 10 days.The onset of the joints afford steeping washing and wet wrapping medicine of descending turbid and clearing heat, once per day, continuous treatment for 10 days.	Drug: Oral medicine of tonifying spleen and descending turbid; Ingredient:cortex phellodendrine, rhizoma atractylodis, radix cyathula, coix seed, cotton Bi Xie,rhizoma smilacis glabrae; Drug: Steeping and washing medicine of descending turbid and clearing heat; Ingredient: turmeric, rhubarb, cortex phellodendrine, rhizoma atractylodis, rhizoma arisaema, angelica dahurica,garden balsam stem, pseudobulbus cremastrae seu pleiones; Drug: Wet wrapping medicine of descending turbid and clearing heat; Ingredient:turmeric, rhubarb, cortex phellodendrine, rhizoma atractylodis, rhizoma arisaema, angelica dahurica, pseudobulbus cremastrae seu pleiones.
Active Comparator: Control group; Take diclofenac sodium enteric-coated, 50 mg, three times a day, continuous treatment for 10 days.	Drug: diclofenac sodium enteric-coated

Outcome Measures

Primary Outcome Measures :

1. The relief of symptoms [ Time Frame: After take the drug 10 days ]
   This measure is a composite outcome according to the joint red and swollen, joint pain, and restricted movement(Excellent:Complete resolution of symptoms, joint function returning to normal. The score of joint pain, joint red and swollen and joint motion is 0.Effective:The main symptoms mostly disappear. Joint function is improvement, but still have the joint red,swollen,pain and limited activity.Invalid: There is no improvement compared with before treatment).The unit of measure is scale.
2. The gout relief index [ Time Frame: After take the drug 10 days ]
   The gout relief index = [gout relief time (days) ÷ 10 (days)] x 100%.The unit of measure is scale.
3. Compare scores of syndrome before treatment and after it. [ Time Frame: After take the drug 10 days ]
   Using nimodipine method: nimodipine = [(scores of syndrome before treatment minus score after it) ÷scores of syndrome before treatment] x 100%.The unit of measure is scale.

Secondary Outcome Measures :

1. Recurrence rate [ Time Frame: Following up for 1 month ]
   Recurrence rate=number of patient recurring acute gouty arthritis ÷total cases of each group.The unit of measure is number.
2. Recurrence time [ Time Frame: Following up for 1 month ]
   Compare the days of cases recurring acute gouty arthritis of each group.The unit of measure is days.
3. The dosage of colchicine of two groups in observation period [ Time Frame: After take the drug 10 days ]
   The unit of measure is mg.
4. Blood uric acid before and after the treatment. [ Time Frame: After take the drug 10 days ]
5. White blood cell count before and after the treatment. [ Time Frame: After take the drug 10 days ]
6. Erythrocyte sedimentation rate before and after the treatment. [ Time Frame: After take the drug 10 days ]

Eligibility Criteria

• Ages Eligible for Study: 18 Years to 75 Years (Adult, Older Adult)
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Criteria

Inclusion Criteria:

1. Aged 18-75, and gender unlimited;
2. The patients must meet western medicine diagnostic criteria for acute gouty arthritis;
3. The patients must meet that integral syndrome differentiation conforms to the spleen beset by dampness syndrome and local syndrome differentiation conforms to blockage disease due to heat.

Exclusion Criteria:

1. Secondary hyperuricemia, such as cancer and perichemotherapy of leukemia, renal failure, cirrhosis of the liver and drug effect(such as diuretics, aspirin, antitubercular agents), et al.
2. Acute infectious diseases, stroke, acute myocardial infarction ,as well as other acute diseases and tumors, rheumatoid arthritis.
3. Patients with peptic ulcer and gastrointestinal bleeding.

Contacts and Locations

Contacts

Contact: Wang Shi Dong, Doctor; 13910965659; wsd3122@sina.cn

Contact: Wu Wen Jing, Master; 15201218433; anna861029@163.com

Locations

China, Beijing

No.3 Hospital Affiliated to Beijing University of Chinese Medicine; Recruiting

Beijing, Beijing, China, 100029

Contact: Lou Xi Nen, Doctor 13601181885 13601181885@163.com

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine; Recruiting

Beijing, Beijing, China, 100700

Contact: Zhao Jiu Li, Doctor 84013229 dzmk@163.net

Sponsors and Collaborators

Beijing University of Chinese Medicine

More Information

• Responsible Party: Wang Shidong, Beijing University of Chinese Medicine
• ClinicalTrials.gov Identifier: NCT02545777
• Other Study ID Numbers: 2015-ZYLC-001
• First Posted: September 10, 2015
• Last Update Posted: September 11, 2015
• Last Verified: September 2015

Keywords provided by Wang Shidong, Beijing University of Chinese Medicine:

Acute gouty arthritis; tonifying spleen and descending the turbid; soaking; wet wrapping

Additional relevant MeSH terms:

Arthritis; Arthritis, Gouty; Joint Diseases; Musculoskeletal Diseases; Gout; Crystal Arthropathies; Rheumatic Diseases; Purine-Pyrimidine Metabolism, Inborn Errors; Metabolism, Inborn Errors; Genetic Diseases, Inborn; Metabolic Diseases; Diclofenac; Anti-Inflammatory Agents, Non-Steroidal; Analgesics, Non-Narcotic; Analgesics; Sensory System Agents; Peripheral Nervous System Agents; Physiological Effects of Drugs; Anti-Inflammatory Agents; Antirheumatic Agents; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Molecular Mechanisms of Pharmacological Action